Omeros | OMER - Ativos





Ativos Alterar Data
Adma Biologics USD 684.21M 19.03M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Cytokinetics USD 1.92B 651.07M 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Immunic USD 189.74M 165.69M 2026-03
Insmed USD 2.1B 26.7M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
MacroGenics USD 345.41M 127.54M 2026-06
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.24B 35.44M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Rockwell Medical USD 52.62M 1.34M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06